This conference includes three broad sessions that tackle challenging clinical issues in gynecologic oncology. 

Offered in a case-based format, the course will provide real-world, practical knowledge to attendees. Each session includes case presentations, topical lectures by experts in the field and concludes with a panel discussion. The sessions will cover:

  • New Technologies to Reduce Morbidity in the Management of Lower Genital Tract Malignancies 
  • Current Challenges in Ovarian Cancer 
  • Management Updates in Uterine Cancer Classification and Treatment Options
Series Information
Series Date:
November 03, 2012
Series Objectives
  • Learners will be able to analyze appropriate use of sentinel node mapping for vulvar, endometrial and cervical;
  • Learners will comprehend current challenges in ovarian cancer management;
  • Learners will be able to describe updates in uterine cancer classification and treatment options;
  • Learners will be gain increased knowledge on operating on lateral ambiguous lesions;
  • Learners will be able to identify the best treatment method for endometrial;
  • Learners will recognize the implication for treatment with adjuvant chemotherapy for platin sensitive patients;
  • Learners will gain knowledge about genomics data and unique tumor management.
Session I: New Technologies to Reduce Morbidity in the Management of Lower Genital Tract Malignancies

Sentinel Lymph Node Biopsy in Women with Vulvar Cancer

  • Review history of the treatment of vulvar cancer and development of SLNB;
  • Update SLNB data from GOG 173; Understand SLNB techniques and pitfalls.

The Increasing Validity of Sentinel Lymph Node Mapping in Uterine and Cervical Cancer

  • Provide an update on the increasing validity of SLN mapping in uterine cancer;
  • present the current role of SLN mapping in cervical cancer;
  • describe future directions in SLN mapping with fertility-sparing surgery in cervical cancer.

Fertility-Sparing Options in Early Cervical Cancer

  • Review the treatment options for women with early stage cervical cancer;
  • discuss current trials for conservative, fertility-sparing surgery for early stage cervical cancer.
Speaker Information
Nadeem Abu-Rustum MD   [ view bio ]
Charles Levenback MD   [ view bio ]
Kathleen Schmeler MD   [ view bio ]
Tags
Clinical trials
International
Sentinel Lymph Node Biopsy
vulvar
uterine
cervical
minimally invasive surgery
early career
medical oncology
obstetrics and gynecology
pathology
radiation oncology
sentinel node mapping
live meeting webcast
ProductAddPrice
Streaming
Attendee: $0.00
Member: $50.00
Full Price: $75.00
Session II: Current Challenges in Ovarian Cancer Management

Genomic Heterogeneity of Ovarian Cancer

Surgical Management of Ovarian Cancer: New(ish) Developments

  • Understand the important factors for risk stratification in predicting surgical complications;
  • be aware of the benefits and elements of Enhanced Surgical Recovery program (“fast-track”);
  • state 3 programmatic strategies to improve the rate of surgical cytoreduction within your practice.

How Can We Improve the Treatment of Recurrent Ovarian Cancer?

Speaker Information
Andrew Berchuck MD   [ view bio ]
Bill Cliby MD   [ view bio ]
Thomas J. Herzog MD   [ view bio ]
Tags
Clinical trials
Genetics
International
Ovarian
minimally invasive surgery
early career
medical oncology
pathology
debulking
live meeting webcast
ProductAddPrice
Streaming
Attendee: $0.00
Member: $50.00
Full Price: $75.00
Session III: Updates in Uterine Cancer Classification and Treatment Options

The Cancer Genome Atlas: Secrets of the Endometrial Cancer Genome

  • Understand the current path forward toward individualized medicine in endometrial cancer;
  • obtain an update on the latest molecular findings affecting responses to targeted therapy;
  • learn how current research will impact future molecular medicine for women.

GOG Protocols and Management of Recurrent Endometrial Cancer

Classification and Current Treatment Strategies for Uterine Sarcomas

  • Appreciate the limitations and ongoing studies evaluating the role of adjuvant therapy for early stage uterine sarcomas;
  • recognize standard and emerging therapies for patients with advanced stage uterine sarcomas based on histologic subtype.
Speaker Information
Douglas Levine MD   [ view bio ]
Matthew A. Powell MD   [ view bio ]
Edward Tanner MD   [ view bio ]
Tags
Clinical trials
Genetics
Pharmacy
International
uterine
endometrial
targeted therapy
early career
medical oncology
pathology
radiation oncology
research science
adjuvant therapy
live meeting webcast
molecular medicine
ProductAddPrice
Streaming
Attendee: $0.00
Member: $50.00
Full Price: $75.00
2012 State of the Art Syllabus

The 2012 State of the Art Conference Syllabus contains all slide presentations in PDF format from the 2012 State of the Art Conference (excluding those that the author requested not be published).

Tags
Clinical trials
Pharmacy
International
Ovarian
uterine
cervical
early career
medical oncology
obstetrics and gynecology
pathology
radiation oncology
allied
advanced practice practitioner
research science
written documents
ProductAddPrice
2012 State of the Art Syllabus
Attendee: $0.00
Member: $50.00
Full Price: $75.00
Individual topic purchase: Selected
Products
All Content
Member: $0.00
Attendee: $0.00
Full Price: $0.00